Investigating the effect of Femi Locket on the fatigue of multiple sclerosis patients

Investigating the effect of Femi Locket on the fatigue of multiple sclerosis patients referring to the clinics of Arak University of Medical Sciences

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240609062052N3

Enrollment

Registered

2024-08-11

Start date

2024-07-13

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis. Multiple sclerosis

Interventions

Intervention 1: Control group: Placebo Group. Intervention 2: Intervention group: Familact Group.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Having a history of multiple sclerosis for 6 months Neurological examination and brain CT scan and ruling out brain tumors and space-occupying lesions Absence of mental illnesses including depression and absence of psychiatric problems and nervous headaches Absence of accompanying diseases that cause fatigue, including thyroid diseases and anemia

Exclusion criteria

Exclusion criteria: Presence of sensitivity to Femilact

Design outcomes

Primary

Measure	Time frame
Fatigue. Timepoint: Before the start of the intervention, 30 and 60 days after the start of the intervention. Method of measurement: "Fatigue Severity Scale" (FSS) standard checklist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Safarabadi

Khomein Faculty of Medical Sciences

mahdisafarabadi@gmail.com+98 86 4622 4142

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026